The CDL Neuro stream provides technical guidance, business insights, and access to capital to startups developing therapeutics, devices, and software tools within the neuroscience space. - Managed a portfolio of pre-seed to seed staged health science startups through the CDL programming. I worked closely with the founding teams to understand and communicate their progress in product development, go-to-market strategy, and finances. - Responsible for sourcing and screening potential portfolio ventures based on program alignment and key success criteria. I utilize various online tools for lead generation and outreach, as well as lead calls with prospective founders and CEOs to discuss the program and assess their venture's fit. After soliciting applications from various leads, I evaluate prospective ventures based on technology differentiation, market opportunity, and team capabilities.- Led the creation of the first CDL-Toronto Impact Report, which highlights the positive difference CDL portfolio companies make on various health, environmental, and social issues.- Responsible for updating the selection thesis within the specialized vertical of Neuroscience. I researched investment trends, innovation areas, and market outlook to determine the direction of next year's recruitment strategy.

Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science and technology-based companies.

Assisted in accounting duties where I was exposed to a variety of new software and systems.

Assisted the General Partners throughout the entire investment process and operational tasks, including deal sourcing, screening, constructing investment memos, and building dynamic models. Overall providing me with comprehensive and in-depth exposure to the world of private equity investing.